News Hub | News Direct

All Industries


Article thumbnail News Release

City of Chicago’s $1.7 Billion Financing of COVID-19 Recovery Plan Wins Bond Buyer’s Deal of the Year

Siebert Williams Shank

A significant bond transaction by the city of Chicago and its Sales Tax Securitization Corporation (STSC) in February 2023 is winner of The Bond Buyer Deal of the Year award. The announcement was made at the financial publisher’s December 5 th annual gala held in New York City and attended by leaders from across the municipal finance industry. Chicago took home the top prize among 10 finalists for its $ 1.7 billion financing of initiatives aimed at Black and Latinx communities disproportionately affected by the COVID-19 pandemic. Siebert Williams Shank & Co. (SWS ), the country’s #1 minority-and-women-owned, non-bank financial firm, teamed with STSC in issuing the bonds to help finance the Chicago Recovery Plan, designed to amplify once-in-a-generation federal funding geared toward a sustainable economic recovery from the pandemic. The city’s first social-designated bonds, paired with a cross-credit refunding tender, will address initiatives related to affordable housing, homelessness support services, environmental justice, and community development. Altogether, the money brings new resources to Chicago neighborhoods that struggle with disinvestment and inequality. City of Chicago Debt Manager Brendan White, who accepted the award said, “Because of our commitment to getting to structural balance and climbing the pension ramp, we were able to afford to pay for these transformative social projects with our fiscal discipline and finally use the STSC to sell high rated bonds to retail investors.” "Our editorial board has chosen a deal that embodies many of the qualities we look for in a Deal of the Year winner," said Mike Scarchilli, editor in chief of The Bond Buyer. "It's a new type of financing for a traditional area of government. It involved a tender refunding that achieved otherwise unattainable goals. It attracted record-setting interest from non-traditional municipal investors. And it's a substantially transformed issuer, with this impressive transaction serving as the exclamation point at the end of its turnaround story.” Chicago took on the ambitious financing after receiving 10 rating upgrades and three positive outlook revisions, by rating agencies, in recognition of a financial turnaround that saw its return to investment-grade rating. SWS served as a Joint Bookrunner on the winning transaction, which was previously named as the Deal of the Year in the Midwest Region category. “I want to congratulate the financial leaders of the City of Chicago and its Sales Tax Securitization Corporation, for this quite exceptional recognition bestowed on them by Bond Buyer,” said Gary Hall, President of Public Finance and Infrastructure at SWS. “Siebert Williams Shank was proud to have been selected by Chicago to serve as a Joint Bookrunner to lead this transaction. The recognition by Bond Buyer is a true reflection of the technical acumen and strength of the team that moved this deal forward. Siebert Williams Shank was also pleased to have been engaged on other top national deals receiving awards.” Each year, The Bond Buyer Deal of the Year awards recognize innovation in municipal finance across the country. Along with Hall, the SWS bankers who worked on the $1.7 billion transaction included Ramon Ortega, Mike Fadel, John Carter, Pat Moran, Jamiyl Fleming, Sherm Swanson, and Ed Tishelman (while at UBS Financial Services Inc.). SWS was additionally recognized for its involvement in three other transactions that were among the Top 10 finalists: the city of Atlanta’s $370 million inaugural issuance of social bonds ( Southeast Region winner ), and the state of Oregon’s $989 million new-money financing for statewide capital funding needs (Far West Region winner ). Additionally, the redevelopment of international Terminal 6 at John F. Kennedy International Airport was selected as the Private Partnership Financing category winner. The Terminal 6 project is led by JFK Millennium Partners, which includes certain equity owners of SWS. The Chicago transaction highlights the city’s steadfast commitment to equitable capital investment intended to create meaningful change in Chicago communities, and its emphasis on utilizing innovative financing alternatives to achieve its mission. Over 10 separate series of bonds, spanning two credits — Chicago's own general obligation, and that of the Sales Tax Securitization Corporation — the city's $1.7 billion financing bolstered major themes of the Chicago Recovery Plan. In addition to the social-designated bonds, which were oversubscribed in retail orders alone, the STSC also executed a cross-credit refunding tender of Chicago GOs for additional savings. With a 22% acceptance rate on over $2 billion of bonds tendered, the STSC reduced aggregate debt service costs and achieved net present value savings of over $55 million on the tender series. The Deal of the Year finalists were named in 10 categories, one in each of The Bond Buyer’s five regional areas of the United States, along with five in additional categories. The Bond Buyer’s editorial board considers a range of factors when judging entries for the Deal of the Year, including creativity, the ability to execute a complex transaction under challenging conditions, the ability to serve as a model for other financings, and the public purpose for which a deal’s proceeds were used. Dually headquartered in New York, NY and Oakland, CA, SWS is an independent non-bank financial services firm that offers investment banking, sales and trading, research, and advisory services. SWS counts 74 Fortune 100 companies among its clients. Contact Details Butler Associates Tom Butler +1 646-213-1802 TButler@ButlerPR.com Christian Agredo +1 646-213-0286 CAgredo@ButlerPR.com Nick Eilerson +1 646-205-7627 NEilerson@ButlerPR.com Company Website https://www.siebertwilliams.com/

December 08, 2023 11:31 AM Eastern Standard Time

Image
Article thumbnail News Release

UDS Earns Highest Accreditation from NCQA for the Third Time in a Row

UDS

United Disabilities Services (UDS) Foundation is thrilled to announce that their Home and Community-Based Services (HCBS) Care Management program has received the highest accreditation from the National Committee for Quality Assurance (NCQA) for the third time in a row. The non-profit, committed to helping older adults, veterans, and people with disabilities lead more independent and fulfilling lives, offers services to those with a range of social and pragmatic needs, like transportation, housing, nutrition, isolation, emotional well-being, and medical problems. NCQA is an independent 501(c)(3) nonprofit organization that improves healthcare quality through accreditation and certifies a wide range of healthcare organizations promoting high-quality care and recognizing high-performing health plans and providers. Evaluated on eight standards that must be met at the highest level for policy and procedures, UDS achieved 100% in the strenuous chart audit review. UDS was one of the first to achieve Long-Term Services and Supports (LTSS) Care Management accreditation from NCQA in 2017 when it was initiated. They were awarded the highest level with a full three-year time frame and then, in 2020, again awarded the full three-year accreditation. Now, in 2023, they have achieved it once more with an A+ rating. William Kepner, the President and CEO of UDS, says, “We are delighted and proud to have once again achieved the highest accreditation from NCQA who have developed excellent standards of care. Our goal is to always provide a great customer experience and outcome, which starts with providing exceptional quality care. I am proud of our UDS support coordination team for their continuing high quality of care and support for those we serve.” We invite you to visit the UDS website at www.udservices.org to learn more about the company and its mission and services. UDS Foundation is a Lancaster, PA-based organization whose mission is to improve the lives of older adults and individuals with disabilities. UDS Foundation accomplishes that by providing a variety of home- and community-based services to help people enjoy safer, happier, and more independent lives in the comfort of their homes. Incorporated in 1970, UDS Foundation has evolved from a small organization to a company providing a network of 12 different programs through several nonprofit entities. UDS Foundation serves older adults, individuals with disabilities, and veterans throughout Pennsylvania and coordinates a network of business partners and satellite offices in multiple counties. For more information, visit www.udservices.org. Contact Details Debra Showalter +1 717-286-0047 madison@rprfirm.com Company Website https://udservices.org

December 08, 2023 11:20 AM Eastern Standard Time

Image
Article thumbnail News Release

Indian computer scientist introduces a novel machine learning method 'Patch2Self to speed up treat neurological disorders efficiently

IPRD

Boston, Massachusetts, Dec. 8, 2023 -- A Budding Computer Scientist Shreyas Fadnavis, from Harvard University & Indiana University Bloomington, has introduced a self-supervised ‘Denoising MRI Technique- Patch2Self’ that makes complex Neurological Examination and Cancer Monitoring an easy and less time-consuming process for health practitioners, enhancing the outcome for the patients. Sharing insights on the innovative Patch2Self Denoising MRI Technique, Shreyas Fadnavis, a Computer Scientist informed that neurological examination is considered to be a complex and daunting process as it is very intricate, overly detailed, eccentric, and capricious. The idea behind developing the ‘Patch2Self dMRI’ technique was to make the scanning process more fast, efficient and less challenging for the health practitioners and patients. Patch2Self (P2S) has emerged as a leading image-denoising technique in the field of diffusion MRI (dMRI) due to its wide applicability and the fact that it doesn’t require specific parameter settings, making it versatile and user-friendly. Furthermore, Patch2Self has been instrumental in the field of oncology, specifically in delineating and measuring treatment responses in cancer. This usage underscores its potential in clinical settings, particularly in enhancing the accuracy of cancer treatment monitoring. Its utility extends to high-field imaging too, showcasing its adaptability to different imaging technologies, added Shreyas. Denoising MRI is a powerful technology that combines the capabilities of artificial intelligence (AI) and machine learning (ML) to analyze healthcare data with unprecedented speed and accuracy. It uses a layered architecture of algorithms to process large amounts of information and extract valuable insights. The benefits of machine learning in healthcare are numerous, including increased efficiency, improved accuracy, and the ability to continuously learn and adapt. Highlighting its role in more specialized medical imaging techniques. In pediatric and neonatal imaging, as discussed by Trò et al. (2023), Patch2Self helps in acquiring clearer images, which is critical given the challenges in scanning these sensitive groups. Additionally, its application in neuroimaging of animals, including mice and macaques (Buscham et al., 2021), points to its broad utility in a range of research contexts beyond human clinical use. Further Shreyas Fadnavis informed, “Tests have shown that this new method, Patch2Self, does a better job cleaning up our brain road maps than other tools out there. It helps provide clearer and more accurate maps without making any assumptions about the noise. Patch2Self is not just limited to conventional denoising but also serves as a preliminary step in super-resolution processes. This expands its application to enhancing the resolution of dMRI images, a crucial aspect in detailed brain studies. Moreover, it is a key component in generative diffusion model-based denoising techniques (Xiang et al., 2023), indicating its role in more advanced, AI-driven image-processing methods. Given its wide range of applications and effectiveness, it's not surprising that Patch2Self has been integrated into popular open-source software packages like DIPY (Garyfallidis et al., 2014), QSIPrep (Cieslak et al., 2021), and Spinal Cord Toolbox (De Leener et al., 2017). These integrations make it accessible to a broader range of users, from clinical researchers to neuroscientists, thereby enhancing the quality of dMRI data processing in various research and clinical settings. Contact Details Shreyas Fadnavis shreyasfadnavis@gmail.com

December 08, 2023 11:09 AM Eastern Standard Time

Image
Article thumbnail News Release

HIBBETT LAUNCHES NEW CLEARED FOR TAKEOFF SERIES FEATURING JORDAN BRAND ATHLETE BRYCE YOUNG

Hibbett, Inc.

Hibbett, Inc., (NASDAQ:HIBB), an athletic-inspired fashion retailer with more than 1,158 Hibbett and City Gear specialty stores nationwide, today announced the launch of Cleared For Takeoff, a new and exclusive digital series featuring NFL rookie quarterback and Jordan Brand athlete Bryce Young of the Carolina Panthers in the inaugural episode. Beginning December 9 th at 8am eastern, the new Cleared For Takeoff episode will be available to watch here and on the Hibbett YouTube channel. Bryce Young, filmed the first episode of Cleared for Takeoff in his current hometown of Charlotte, North Carolina at the Panthers Practice Facility and a local Hibbett store. Young shared how focusing on his dreams as a kid led him on a path to become a first-round draft pick for the Panthers. “My dream began in Pasadena, California at Victory Park running around, having fun and not worrying about anything but playing football. Football is where I found myself and not just in sports, but through life.” Young talked about how hard work, encouragement from his mentors and his own self-belief, led him to football success. “Challenges are inevitable in sports and life. The game gave me a sense of direction and a sense of accomplishment. No matter how hard, ultimately it allowed me to grow.” “We are excited to kick off our first episode of Cleared For Takeoff while celebrating the launch of the iconic Air Jordan 11 Gratitude,” said Sarah-Sharp Wangaard, VP Marketing, Hibbett. “We believe in inspiring kids and providing opportunities for them to “take flight,” follow their dreams and live boldy without limits. We appreciate Bryce Young, Jordan Brand and the Jordan Wings Initiative for helping us bring this episode to life.” During the episode, Young is seen stopping by Hibbett in Charlotte and visiting with 23 Jordan Wings students from the Carolina Youth Coalition and Rise2Impact, both partners of the Jordan Wings Initiative. The purpose of the Jordan Wings Initiative - which works with partners globally - is to unlock access to education and mentorship, as well as, create inspiration and access that helps youth create a better future. It is inspired by Michael Jordan’s legacy of greatness and commitment to education. The students got the surprise of their lives when Young showed up to meet with them and discuss how he approached his own journey to success. Young encouraged the students to follow their own dreams and to find their passion. “Dreams are something that have always guided me and always pushed me. The beautiful thing is that there is no limit to what it can be. I’m grateful to be in the position I am to inspire the next generation. Understand that no matter where you’re from, your background, what is against you, or isn’t, all things are possible.” Young then ended his visit by gifting the students with their very own pairs of Air Jordan 11’s. Hibbett also presented each student in attendance with a $1000 giftcard to enjoy a private shopping experience and purchase shoes for the year ahead. Fans can look forward to more Cleared For Takeoff episodes coming in 2024. About Hibbett, Inc. Hibbett, headquartered in Birmingham, Alabama, is a leading athletic-inspired fashion retailer with 1,158 Hibbett and City Gear specialty stores, located in 36 states nationwide. Hibbett has a rich history of convenient locations, personalized customer service and access to coveted footwear, apparel and equipment from top brands like Nike, Jordan, and adidas. Consumers can browse styles, find new releases, shop looks and make purchases online or in their nearest store by visiting www.hibbett.com. Follow us @hibbettsports and @citygear on Facebook, Instagram and Twitter. Contact Details Wendy Yellin pr@hibbett.com Company Website https://www.Hibbett.com

December 08, 2023 10:02 AM Eastern Standard Time

Image
Article thumbnail News Release

Monogram Orthopedics’ Surgical Robot Now Reality As Company Delivers First System

Benzinga

By Meg Flippin, Benzinga Robotic surgeries are going mainstream for a good reason: they make it easier for doctors to perform complex surgeries. Monogram Orthopedics Inc. (NASDAQ: MGRM), which aims to revolutionize orthopedic joint replacement surgery with its robotic technology, just got one step closer to achieving that with its recently announced first robot delivery. The Austin, Texas-based medical technology company recently announced the delivery of its first surgical robot to one of the world’s largest international robotics distributors. The delivery marks the first commercial sale for Monogram Orthopedics, validating its technology, which eventually aims to link patient-optimized 3D printed implants with advanced robotics. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. Strategic Roadmap “Delivering our first robot and realizing our first commercial revenues validates our technology and represents a pivotal milestone for our strategic roadmap,” said Ben Sexson, Chief Executive Officer of Monogram Orthopedics. “Our system is performing at an extremely high level. We now look forward to seeing how our robot competes and scales in the real world. We hope to see the mBôs robot contribute to advancing the standard of care for orthopedic patients worldwide.” Orthopedics is a large and growing market, with joint replacements forecast to grow by a CAGR of 7.9% through 2030 to over $37 billion, according to Fortune Business Insights. While North America is the largest market today, opportunities outside the United States are quickly developing. Due to increased healthcare spending, rapidly expanding healthcare infrastructure, a growing middle class and increased medical tourism, the international market for joint replacements will also increase over the coming decade. Monogram’s strategy is to pursue commercial traction internationally — and leverage clinical data from them — while simultaneously working to obtain FDA clearance in the US for its robotics systems. “Our orthopedic robotic systems are attractive to these growing markets for several reasons. Firstly, we are designing an orthopedic robot, not just a knee robot. A multi-application system is much more capital-efficient. Second, the autonomous nature of our system aims to improve the standard of care and safety of these procedures”, said Noel Knape, CFO of Monogram. “Our operating procedure leverages patient-specific CT Scans and active autonomous cutting to minimize the risk of soft tissue damage and enable all surgeons to focus on planning. We expect these attributes to drive market adoption in these emerging markets”. Monogram aims to improve the standard of care in orthopedic joint replacement surgery with advanced, next-generation active surgical robotics. Approximately 88% of knee replacement surgeries (the company's first addressable market) are still manual. The mBôs robot aims to combine safety, ease of use, streamlined cost, novel implant design, broad clinical functionality, and speed to help drive the next wave of robotic adoption in orthopedics. Revolutionizing The Market “We are excited to begin our commercial journey,” said Ben Sexson, CEO. “We believe the market potential for autonomous robotics that integrate augmented reality and machine learning workflows to enhance the surgery is significant. The company plans to demonstrate this value proposition in a hosted live stream demo.” The company recently announced it will host a live stream product demonstration of features of its commercial robot on Thursday, December 14, 2023, at 11:00 a.m. Eastern Time. The pre-recorded video will feature Monogram's mBôs Surgical Robot. The demo follows Monogram's recent delivery of its first surgical robot to one of the largest global robot distributors and will showcase the technical advances of its system. Monogram Product Demo Live Stream Date: Thursday, December 14, 2023 Time: 11:00 a.m. Eastern Time Livestream: https://www.monogramorthopedics.com/webinar In pre-clinical trials, Monogram’s robot was able to complete simulated orthopedic robotic surgery in times competitive with current state-of-the-art systems. The goal is to significantly reduce these surgical times. The live stream demo should showcase how that could be possible. The mBôs robot aims to combine safety, ease of use, streamlined cost, novel implant design, broad clinical functionality and speed to help drive the next wave of robotic adoption in orthopedics. Conclusion Next-generation robotics will help drive the future of orthopedic medicine. Surprisingly, it is likely that emerging markets, which have easier regulatory hurdles will lead the way with the adoption of advanced technologies. Shifting demographics and aging populations will continue to drive demand for decades to come. Monogram’s vision is to advance the standard of care in orthopedics with a robotic solution that makes robotic surgeries easier and faster with uncompromised safety and accuracy. Monograms engender personalization – Monogram Orthopedics believes the future of robotics will be personalized, with patients getting personalized surgical plans optimized to their unique needs. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

December 08, 2023 09:55 AM Eastern Standard Time

Image
Article thumbnail Digital Asset Direct

Ho-Ho-Holiday Gifts

News Media Group, Inc.

Contact Details News Media Group, Inc. Karl Wayne +1 334-440-6397 karl@newsmg.com Company Website https://newsmg.com/

December 08, 2023 09:24 AM Eastern Standard Time

Video
Article thumbnail News Release

Indra Intelligence's AI tool Inspire enables rapid persona creation and generation of associated interests

Prodigy Press Wire

Indra Intelligence, an expert in web development, digital marketing, and eCommerce, unveils Inspire, the ultimate tool for unlocking the power of data and personas. With Inspire, you can dive deep into the interests, activities, sports, entertainment, influencers, and health and wellness preferences of your primary persona groups. It's easy and quick to build out detailed profiles and even generate stunning imagery to bring them to life. Regardless of your product category or target market, Inspire can supercharge your brand. Indra Intelligence has taken things upstream and harnessed the power of generative AI to make large brand profiling a breeze. The Inspire platform begins with a Brand level generation of marketing deliverables, including market and competitor analysis, CRO and SEO checklists, blog posts, and more. But the real magic happens within the Personas and Products levels. Inspire Platforms generation of Personas With Inspire, users can create a multitude of Personas custom-built for their brand, unlocking a whole new level of understanding and engagement. As users cycle through and drill down into each Persona, they can continue to generate a wide range of relevant interests, product and ad creative concepts, and actionable marketing deliverables like email campaigns, ad set targets, and blog posts specifically tailored to that Persona. In the Products section, users can upload their product lists and with the click of a button generate a robust range of marketing assets specific to each product. These can include ad concepts and product variations, as well as SEO keyword lists and Influencer targets that are directly tied to each individual product. Within each level of the Inspire platform, users can set the preferred style and/or tone of voice for their marketing deliverable and associated images, while also having the flexibility to upload, edit and regenerate imagery or text to match their style. There’s no end to the possibilities of generating and regenerating actionable materials related to the user’s Brand, Products, and Personas. It's a wealth of inspiration that helps organize and refine your ideas. Additionally, Inspire offers a helpful conversational AI assistant that is pre-programmed to understand the user’s brand and all of the associated materials uploaded to or generated within their account. Users can leverage the AI assistant to help complete their brand profiles, optimize and edit their marketing deliverables, and as a general knowledge tool that’s fine-tuned to their brand. AI generated advertising ideas, by Inspire Platform Indra Intelligence emphasizes the fact that In the age of AI, creativity reigns supreme, and hard work and execution are increasingly giving way to rapid-fire idea generation. The world is changing, and those who can dream up ideas quickly will thrive. The diligent worker bees of the past may find it challenging to keep up, but as humans, we're adaptable. Media Contact Name: Ben Scheuer Email: info@indraintelligence.com Release ID: 835319

December 08, 2023 09:00 AM Eastern Standard Time

Image
Article thumbnail News Release

G-NiiB Oral Microbiome Immunity Formula SIM01 Alleviates Post-COVID-19 Conditions

G-NiiB GenieBiome

HONG KONG SAR - Media OutReach Newswire - 8 December 2023 - Hong Kong's leading biomedical and microbiome technology company, G-NiiB GenieBiome, is pleased to announce that a ground-breaking large-scale randomised, double-blind, placebo-controlled clinical trial ("the Trial") conducted on the efficacy of SIM01, an oral microbiome immunity formula developed by a top-notch medical school in Hong Kong, involving 463 patients who had contracted COVID-19, has strongly proved that the consumption of SIM01, an oral microencapsulated live bacteria formula, could significantly improve the gut microbiota after six months and lead to remarkable alleviation of post-COVID-19 sequelae ("long COVID"), encompassing a range of symptoms affecting different systems and organs. The findings of the Trial were published yesterday in The Lancet Infectious Diseases, the most authoritative international medical journal in infectious diseases. G-NiiB GenieBiome’s flagship product, G-NiiB Immunity+, contains the oral microbiome immunity formula SIM01. The Trial has robustly demonstrated the exceptional efficacy of SIM01 in alleviating post-COVID-19 conditions, sending a significant breakthrough and a sliver of hope for the 65 million individuals worldwide who have been profoundly impacted by the long COVID. It is widely acknowledged that post-COVID-19 symptoms exhibit substantial interindividual variability, complexity, and long-haul span, posing a dual challenge to the patient's physiological and psychological well-being. Given the current lack of targeted and effective therapies, it has emerged as one of the most formidable health challenges in the aftermath of the COVID-19 pandemic. In its August 2021 publication, The Lancet mentioned that long COVID is the primary challenge of modern medicine. The oral microencapsulated live bacteria formula SIM01, published in The Lancet Infectious Diseases this time, is the flagship product of G-NiiB GenieBiome. Multiple clinical studies have confirmed its effectiveness. This very study, known as the RECOVERY study, is the first global clinical research to testify that SIM01 can improve gut microbiota and effectively alleviate post-COVID-19 symptoms, including fatigue, memory loss, difficulty in concentration, gastrointestinal upset and general unwellness. The study results further highlight the interconnectedness of the "Microbiome-Gut-Brain Axis," illustrating how probiotic metabolites absorbed through the gut can contribute to improving brain function. This also underscores the potential of restoring healthy gut microbiota as a novel intervention and strategy for addressing post-COVID-19 neurological symptoms. The publication of these research findings in The Lancet Infectious Diseases signifies authoritative recognition of their scientific and pioneering property, as well as a strong affirmation of SIM01's possibility to improve post-COVID-19 symptoms and enhance overall immune performance in patients. Ms. Rachel Fan, CEO of G-NiiB GenieBiome, stated, "The publication of the Trial on G-NiiB's microbiome immunity formula, SIM01, in the medical journal The Lancet Infectious Diseases, is undoubtedly a scientific feat and a significant milestone for G-NiiB GenieBiome. It represents a great recognition of the leadership, judgment, and expertise of our founder and Chief Scientific Advisor, showcasing our leading position and innovative capabilities in microbiome research. It also serves as a strong testimony of our professional competence and product quality, demonstrating that our core technology has received authoritative approbation from the international medical community. This is considerable progress and an outstanding achievement for a pioneering company to keep a foothold in the microbiome arena. We are immensely proud." Besides, "The practical significance of this study lies in proving the scientific efficacy and multiple feasibilities of SIM01, inaugurating new avenues for microbiome research and human health exploration. From a societal perspective, G-NiiB's microbiome immunity formula, SIM01, presents the potential to offer a fresh choice for individuals suffering from long COVID while making seminal contributions to the fight against COVID-19 and other diseases. G-NiiB GenieBiome is committed to continuing its investment in innovative research and cutting-edge development, steadfastly striving to improve human health and tackle various disease challenges." Ms. Rachel Fan, CEO of G-NiiB GenieBiome, background is the clinical trial published in The Lancet Infectious Diseases. Utilising advanced metagenomic sequencing data, patented artificial intelligence, and microencapsulation technology, G-NiiB GenieBiome has introduced three patented oral microbiota formulations. They are SIM01, a microbiome precision immunity formula designed to enhance the immune system; SMT04, a microbiome precision gut protective formula to preserve intestinal health; and SIM03, a microbiome precision children immunity formula to develop diverse rainbow immunity. Clinical data from a renowned medical school in Hong Kong have supported these formulations. The team is currently researching to develop innovative formulations to treat and alleviate complex conditions such as fatty liver and adult eczema, aiming to meet the evolving needs of the health supplement market. Ms. Rachel Fan further added, "Our core team members excel in their respective spheres. Our collective goal is to blaze innovative transformation in the field of human health through microbiome research. By leveraging the leap we made in microbiota research, the team strives to significantly improve disease prevention, diagnosis, and treatment, sequentially accelerating the transition into a new era of microbiota-centric medicine." G-NiiB GenieBiome G-NiiB GenieBiome is a biotechnology company founded by world-renowned clinician-scientists and supported by a multidisciplinary team of experts in microbiology, metagenomics, bioinformatics, disease biomarkers, food technology, clinical trials, IP development and commercialization. For over a decade, our team has pioneered the use of microbiome with evidence-based science to tackle a myriad of diseases, including colorectal cancer, obesity, atopic eczema, autism, and mood disorders, revolutionizing the prevention, diagnosis, and treatment of disease. Our precision portfolio of G-NiiB includes diagnostic and risk prediction tests, next-generation microbiome precision formulas, and precision medicine tailored for the Asian population. Our vision is to be a game changer in human health with microbiome solutions. Contact Details Tim Chan timchan@g-niib.com Company Website https://www.g-niib.com

December 08, 2023 09:00 AM Eastern Standard Time

Image
Article thumbnail News Release

Eric Spofford Announces Cashflow Is King Training Program

Glazers Media

New York City, Dec. 8, 2023 ( Glazer Media ) -- Eric Spofford, a leading expert in real estate and entrepreneurship, is excited to announce the launch of the Cashflow Is King Training Program. This comprehensive program is designed to empower individuals with the knowledge and skills they need to take control of their financial future and achieve lasting financial stability. To learn more about the Cashflow Is King Training Program and to take advantage of a special limited-time offer, please visit: Cashflow Is King Training Program The Cashflow Is King Training Program is a one-of-a-kind educational initiative that provides participants with the tools and strategies necessary to understand the intricacies of personal finance, budgeting, investing, and wealth creation. Eric Spofford, a seasoned business mentor with a proven track record, will lead the program, sharing his extensive knowledge and insights gained over years of experience in the financial industry. Participants in the Cashflow Is King Training Program can expect to gain a comprehensive understanding of key financial concepts, including: Budgeting: Learn how to create a budget that aligns with your financial goals and lifestyle, allowing you to manage your income and expenses effectively. Investing: Discover the principles of smart investing, including how to build and diversify your investment portfolio for long-term wealth accumulation. Debt Management: Gain strategies for managing and reducing debt, freeing up more of your income for saving and investing. Wealth Building: Understand the techniques for building and growing wealth over time, including how to make your money work for you through various investment vehicles. Eric Spofford's Cashflow Is King Training Program is an invaluable resource for anyone seeking to enhance their financial literacy and secure their financial future. By enrolling in this program, you'll have access to expert guidance, practical tips, and a supportive community of like-minded individuals committed to achieving financial success. To kickstart your journey towards financial empowerment and take advantage of a limited-time special offer, visit the Cashflow Is King Training Program at https://www.cashflowiskingtraining.com/free-training. About Eric Spofford: Eric Spofford is a respected real estate and entrepreneurship expert with a mission to help individuals achieve financial freedom. With a background in finance and a passion for educating others, Eric has been empowering people with the knowledge and tools they need to take control of their financial destinies. For more information about Eric Spofford and his work, please visit https://www.cashflowiskingtraining.com and social media YouTube | Instagram | Facebook | TikTok Contact Details Eric Spofford coaching@ericspofford.com Company Website https://ericspofford.com/

December 08, 2023 08:43 AM Eastern Standard Time

Image
1 ... 581582583584585 ... 3766